These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24294139)

  • 21. Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease.
    Gunnarsson R; El-Hage F; Aaløkken TM; Reiseter S; Lund MB; Garen T; ; Molberg Ø
    Rheumatology (Oxford); 2016 Jan; 55(1):103-8. PubMed ID: 26320136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers.
    Kaizer AM; Lindblade C; Clancy R; Tebo AE; Drewes B; Masson M; Chang M; Fraser N; Buyon JP; Cuneo BF
    Am J Obstet Gynecol; 2022 Nov; 227(5):761.e1-761.e10. PubMed ID: 35690080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Ro52/TRIM21 serological subsets identify differential clinical and laboratory parameters.
    Lee AYS; Lin MW; Reed JH
    Clin Rheumatol; 2022 Nov; 41(11):3495-3501. PubMed ID: 35871174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis.
    Martel ME; Leurs A; Launay D; Behal H; Chepy A; Collet A; Sanges S; Hachulla E; Dubucquoi S; Dauchet L; Sobanski V
    Autoimmun Rev; 2024 May; 23(5):103536. PubMed ID: 38555075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current state of technologies and recognition of anti-SSA/Ro antibodies in China: A multi-center study.
    Chen YL; Hu CJ; Peng LY; Wang CH; Zhao Y; Zhang W; Liu DZ;
    J Clin Lab Anal; 2021 Dec; 35(12):e24045. PubMed ID: 34674312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
    Ghillani P; André C; Toly C; Rouquette AM; Bengoufa D; Nicaise P; Goulvestre C; Gleizes A; Dragon-Durey MA; Alyanakian MA; Chretien P; Chollet-Martin S; Musset L; Weill B; Johanet C
    Autoimmun Rev; 2011 Jul; 10(9):509-13. PubMed ID: 21447407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Significance of Different Profiles of anti-Ro Antibodies in Connective Tissue Diseases.
    Yang HT; Hong XP; Guo JW; Zhong XL; Liao R; Liu CL; Liu LX; Li K; Chen YL; Liu DZ
    J Immunol Res; 2023; 2023():9195157. PubMed ID: 36741231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus.
    Zimmermann C; Smolen JS; Graninger W; Petera P; Fabini G; Hassfeld W; Höfler E; Steiner G
    J Rheumatol; 1996 Nov; 23(11):1897-903. PubMed ID: 8923363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus.
    Hoffman IE; Peene I; Meheus L; Huizinga TW; Cebecauer L; Isenberg D; De Bosschere K; Hulstaert F; Veys EM; De Keyser F
    Ann Rheum Dis; 2004 Sep; 63(9):1155-8. PubMed ID: 15308527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific testing for "isolated" anti-52 kDa SSA/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value.
    Langguth DM; Morris S; Clifford L; Wilson RJ; Neil J; Hogan PG; Wong RC
    J Clin Pathol; 2007 Jun; 60(6):670-3. PubMed ID: 17557869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.
    Fritsch C; Hoebeke J; Dali H; Ricchiuti V; Isenberg DA; Meyer O; Muller S
    Arthritis Res Ther; 2006; 8(1):R4. PubMed ID: 16356190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.
    Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Wang M; Baron M; Fritzler MJ; ; ;
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S131-5. PubMed ID: 26315678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies to the functionally active RING-domain of Ro52/SSA are associated with disease activity in patients with lupus.
    Kvarnström M; Dzikaite-Ottosson V; Ottosson L; Gustafsson JT; Gunnarsson I; Svenungsson E; Wahren-Herlenius M
    Lupus; 2013 Apr; 22(5):477-85. PubMed ID: 23554036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
    Gál I; Lakos G; Zeher M
    Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Ro52/TRIM21 antibodies are associated with aberrant inflammatory circuits in patients with systemic autoimmune rheumatic diseases.
    Amezcua-Guerra LM; Pérez-García LF; Jiménez-Rojas V; Márquez-Velasco R; Silveira LH
    Gac Med Mex; 2023; 159(1):55-64. PubMed ID: 36930561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year.
    Mosca M; Tavoni A; Neri R; Bencivelli W; Bombardieri S
    Lupus; 1998; 7(2):95-100. PubMed ID: 9541093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
    Zampeli E; Mavrommati M; Moutsopoulos HM; Skopouli FN
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):134-141. PubMed ID: 32083547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.
    Franceschini F; Calzavara-Pinton P; Valsecchi L; Quinzanini M; Zane C; Facchetti F; Airò P; Cattaneo R
    Adv Exp Med Biol; 1999; 455():167-71. PubMed ID: 10599339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stress-induced cell surface expression and antigenic alteration of the Ro/SSA autoantigen.
    Igarashi T; Itoh Y; Fukunaga Y; Yamamoto M
    Autoimmunity; 1995; 22(1):33-42. PubMed ID: 8882420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Latest update on the Ro/SS-A autoantibody system.
    Schulte-Pelkum J; Fritzler M; Mahler M
    Autoimmun Rev; 2009 Jun; 8(7):632-7. PubMed ID: 19393201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.